Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Blockchain law: Can there be law without people?
New York Law Journal
Two seemingly unrelated recent developments in the world of blockchain are now posing the same odd question: Can there be law without people?
Blockchain technology has enabled a world of “smart contracts”—programs stored on the blockchain that automatically run and carry out predetermined tasks when predetermined conditions are met. These smart contracts are often integrated with so-called decentralized autonomous organization (DAOs), loose groups of tokenholders who effectuate decision making through software protocols.
Can DAOs, natural persons or other legal entities be held legally responsible when outcomes that are caused or enabled by those “smart contracts” are ones that society seeks to prevent and hold unlawful? Or is no one legally responsible, so that whatever these “smart contracts” might do is simply beyond the power of the institution of the law to remedy or prevent?
Robert A. Schwinger explores recent developments in this edition of his New York Law Journal Blockchain law column.
Download the full New York Law Journal article, "Can there be law without people?"
Partner
Email
robert.schwinger@nortonrosefulbright.com
Recent publications
Publication
African nations need to present a united front at COP29 to ensure their voices are heard
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .